"","scenario","cases","severe_disease","hosp","death","YLL"
"1","25% prioritisation"," -15,543 (-0.2%)","  -1,436 (-5%)","  -3,021 (-2.3%)","    -157 (-7.6%)","  -1,467 (-5.3%)"
"2","50% prioritisation"," -13,656 (-0.1%)","  -1,479 (-5.2%)","  -3,083 (-2.3%)","    -162 (-7.9%)","  -1,512 (-5.5%)"
"3","75% prioritisation"," -12,513 (-0.1%)","  -1,492 (-5.2%)","  -3,096 (-2.3%)","    -164 (-8%)","  -1,526 (-5.5%)"
"4","booster at three months (at risk only)"," -96,437 (-1%)","  -6,811 (-23.9%)"," -14,101 (-10.5%)","    -721 (-35.1%)","  -6,789 (-24.5%)"
"5","additional primary doses"," -23,724 (-0.2%)","  -1,536 (-5.4%)","  -3,375 (-2.5%)","    -164 (-8%)","  -1,553 (-5.6%)"
"6","additional booster doses","-123,242 (-1.3%)","  -6,806 (-23.9%)"," -14,757 (-11%)","    -702 (-34.1%)","  -6,701 (-24.2%)"
"7","broaden to <18 pregnant individuals"," -23,724 (-0.2%)","  -1,536 (-5.4%)","  -3,375 (-2.5%)","    -164 (-8%)","  -1,553 (-5.6%)"
